Arimoclomol: Difference between revisions

Arimoclomol
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Latest revision as of 00:45, 20 February 2025

An investigational drug for neurodegenerative diseases

Arimoclomol is a pharmacological agent that has been investigated for its potential therapeutic effects in various neurodegenerative diseases. It is known for its ability to modulate the heat shock response, a cellular defense mechanism against stress.

Mechanism of Action[edit]

Arimoclomol functions by amplifying the production of heat shock proteins (HSPs), which are crucial in maintaining cellular protein homeostasis. These proteins assist in the proper folding of nascent proteins and the refolding or degradation of misfolded proteins, thus protecting cells from stress-induced damage. By enhancing the heat shock response, arimoclomol aims to mitigate the pathological processes associated with neurodegenerative conditions.

Therapeutic Applications[edit]

Arimoclomol has been studied in the context of several neurodegenerative disorders, including:

In these conditions, the accumulation of misfolded proteins and cellular stress are key pathological features. Arimoclomol's ability to boost the heat shock response offers a potential therapeutic strategy to alleviate these issues.

Clinical Trials[edit]

Clinical trials have been conducted to evaluate the efficacy and safety of arimoclomol in patients with neurodegenerative diseases. These trials aim to determine the drug's impact on disease progression, symptom management, and overall quality of life for patients.

Safety and Side Effects[edit]

The safety profile of arimoclomol has been assessed in various clinical studies. Common side effects reported include mild gastrointestinal disturbances and headache. The drug is generally well-tolerated, but ongoing studies continue to monitor its long-term safety.

Future Directions[edit]

Research into arimoclomol is ongoing, with scientists exploring its potential applications in other diseases characterized by protein misfolding and cellular stress. The drug's ability to modulate the heat shock response makes it a promising candidate for further investigation in the field of neurodegeneration.

Related Pages[edit]

Arimoclomol
Arimoclomol

Arimoclomol
Arimoclomol

@@ Line 1: / Line 1: @@
-'''Arimoclomol''' is an experimental drug designed to amplify the production of [[heat-shock proteins]] (HSPs) within the body. These proteins play a crucial role in maintaining cellular function and protecting against [[cell stress]]. Arimoclomol works by enhancing the body's natural stress response, potentially offering therapeutic benefits for diseases characterized by abnormal protein accumulation and cellular stress, such as [[neurodegenerative diseases]].
+{{Short description|An investigational drug for neurodegenerative diseases}}
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 477002123
+| image = Arimoclomol.svg
+| image_size = 200px
+| image_alt = Structural formula of Arimoclomol
+}}
+'''Arimoclomol''' is a pharmacological agent that has been investigated for its potential therapeutic effects in various [[neurodegenerative diseases]]. It is known for its ability to modulate the [[heat shock response]], a cellular defense mechanism against stress.
 ==Mechanism of Action==
-Arimoclomol acts by entering cells and stimulating the production of heat-shock proteins. It does this by binding to the [[Heat shock factor 1]] (HSF1), a transcription factor that is activated under conditions of cellular stress. Upon activation, HSF1 initiates the transcription of genes encoding heat-shock proteins. By amplifying this natural protective mechanism, arimoclomol helps to stabilize misfolded proteins, facilitate their proper folding, and promote their degradation, thereby reducing cellular toxicity.
+Arimoclomol functions by amplifying the production of [[heat shock proteins]] (HSPs), which are crucial in maintaining cellular protein homeostasis. These proteins assist in the proper folding of nascent proteins and the refolding or degradation of misfolded proteins, thus protecting cells from stress-induced damage. By enhancing the heat shock response, arimoclomol aims to mitigate the pathological processes associated with neurodegenerative conditions.
+==Therapeutic Applications==
+Arimoclomol has been studied in the context of several neurodegenerative disorders, including:
-==Clinical Trials==
+* [[Amyotrophic lateral sclerosis]] (ALS)
-Arimoclomol has been under investigation for its potential application in several neurodegenerative and neuromuscular diseases, including [[Amyotrophic lateral sclerosis]] (ALS), [[Niemann-Pick disease type C]] (NPC), and [[Inclusion body myositis]] (IBM). Clinical trials have explored its safety, tolerability, and efficacy in these conditions.
+* [[Niemann-Pick disease type C]]
+* [[Inclusion body myositis]]
-===Amyotrophic Lateral Sclerosis===
+In these conditions, the accumulation of misfolded proteins and cellular stress are key pathological features. Arimoclomol's ability to boost the heat shock response offers a potential therapeutic strategy to alleviate these issues.
-In ALS, arimoclomol has been evaluated for its ability to slow disease progression. Early-phase clinical trials suggested some potential benefits, leading to further studies to assess its impact on survival and quality of life in ALS patients.
-===Niemann-Pick Disease Type C===
+==Clinical Trials==
-For NPC, a rare genetic disorder characterized by the accumulation of lipids in cells, arimoclomol has shown promise in delaying disease progression. Clinical trials have focused on its safety and efficacy in improving neurological function and extending lifespan.
+Clinical trials have been conducted to evaluate the efficacy and safety of arimoclomol in patients with neurodegenerative diseases. These trials aim to determine the drug's impact on disease progression, symptom management, and overall quality of life for patients.
-===Inclusion Body Myositis===
+==Safety and Side Effects==
-In IBM, a progressive muscle disorder, arimoclomol's potential to enhance muscle function and reduce deterioration has been the subject of research. However, the outcomes of these studies have yet to provide conclusive evidence of its benefits.
+The safety profile of arimoclomol has been assessed in various clinical studies. Common side effects reported include mild gastrointestinal disturbances and headache. The drug is generally well-tolerated, but ongoing studies continue to monitor its long-term safety.
-==Regulatory Status==
+==Future Directions==
-As of the last update, arimoclomol has not received approval from major regulatory bodies such as the [[U.S. Food and Drug Administration]] (FDA) or the [[European Medicines Agency]] (EMA). Its development and review process continues, with the drug's sponsor seeking approval for specific indications based on the results of clinical trials.
+Research into arimoclomol is ongoing, with scientists exploring its potential applications in other diseases characterized by protein misfolding and cellular stress. The drug's ability to modulate the heat shock response makes it a promising candidate for further investigation in the field of neurodegeneration.
-==Potential and Challenges==
+==Related Pages==
-The development of arimoclomol represents a novel approach to treating diseases associated with protein misfolding and cellular stress. Its mechanism, focusing on enhancing the body's natural protective responses, offers a potentially wide-ranging application across various conditions. However, the challenges in translating promising preclinical findings into clinical success highlight the complexity of treating neurodegenerative and neuromuscular diseases. Further research and clinical trials are necessary to fully understand arimoclomol's therapeutic potential and safety profile.
+* [[Heat shock protein]]
+* [[Neurodegenerative disease]]
+* [[Protein folding]]
-[[Category:Experimental drugs]]
+[[Category:Investigational drugs]]
-[[Category:Neurodegenerative disease drugs]]
+[[Category:Neurodegenerative disorders]]
-{{pharmacology-stub}}
+<gallery caption="Arimoclomol">
+File:Arimoclomol.svg|Arimoclomol
+</gallery>
+<gallery caption="Arimoclomol">
+File:Arimoclomol.svg|Arimoclomol
+</gallery>